FAQ/Help |
Calendar |
Search |
Today's Posts |
06-25-2009, 01:40 AM | #1 | ||
|
|||
News Gatherer
Community Support Team
|
HealthDay - WEDNESDAY, June 24 (HealthDay News) -- A new cancer drug called olaparib worked well in an early clinical trial against breast, ovarian and prostate cancers in individuals who were genetically vulnerable to developing these malignancies.
Read the full article... (From Yahoo Diseases) |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Men With BRCA Gene Mutations Unaware of Cancer Risks (HealthDay) (Yahoo) | Men's Health |